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Running Title: This is a prospective cohort study using the validated body  
 
dysmorphic disorder questionnaire to screen for the prevalence of this condition in 
septorhinoplasty patients. We provide a model for their management discuss the 
benefits of operating on such patients.  
 
Corresponding author e-mail id: jajoseph@doctors.org.uk 
 
Introduction 
People with body dysmorphic disorder (also known as BDD) have a preoccupation 
with a perceived defect in their appearance. The “flaws” are often either a normal 
physical variation, or appear objectively only slight to others, yet cause enormous 
shame and interference in the person’s life.1 The prevalence of BDD in the general 
population is approximately 2%2. Those affected have much higher rates of cosmetic 
surgery and suicidal ideation than the general population. The average age of onset 
is in mid-to-late adolescence but it takes on average 10 years before psychiatric 
treatment is received3,4.  
 
Patients with BDD perform repetitive behaviours such as mirror gazing and have 
clinically significant distress and impairment in their ability to interact socially and at 
work5. In the diagnosis of BDD, the preoccupation must not be better accounted for 
by another mental health disorder such as body image problems in anorexia 
nervosa6. To fulfil diagnostic criteria individuals must think about their area of 
concern for more than 1 hour per day5. The mainstay of treatment for those 
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diagnosed with BDD is cognitive behaviour therapy7 with medical treatment with a 
selective serotonin re-uptake inhibitor usually reserved for those who do not respond 
to this treatment8. 
 
Many sufferers present to various specialists such as ear, nose and throat, plastic 
and maxillofacial surgeons as well as dermatologists with the aim of having the 
perceived cosmetic defect corrected in the hope that it will improve their quality of 
life. However satisfaction with cosmetic surgery is highly unlikely and unpredictable 
in this group of patients9. As such, it is critical to identify these patients as early as 
possible and certainly before any surgery is considered. A study in a dermatology 
clinic found the rate of BDD among those seeking cosmetic treatment of 14%10. 
 
In our large septorhinoplasty practice, experience has shown undiagnosed BDD 
often results in poor patient satisfaction. The nose is the most common area of 
concern (56% of patients) among those with a diagnosis of BDD11,12.    
 
Method: 
Ethical Considerations: 
Ethical approval was sought and obtained from our local ethics board.  
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Objectives: 
The main objective was to determine the prevalence of those at risk of body 
dysmorphic disorder in our practice and whether surgical correction could be 
considered in these patients 
 
Design: 
A prospective cohort study 
 
Setting:  
The study was carried out in our tertiary referral rhinology and facial plastics surgery 
unit at the Royal National Throat, Nose and Ear Hospital in collaboration with the 
clinical psychology team of the Plastic & Reconstructive Surgery Department of the 
Royal Free London NHS Foundation Trust. 
 
Participants and Data Collection: 
This prospective study was conducted over a 6 month period from September 2014 
to March 2015. All patients who were referred to the tertiary level specialist rhinology 
clinic for consideration of septorhinoplasty surgery for both cosmetic and functional 
concerns were asked to participate in the study and to give verbal and written 
consent.  
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Patients were asked to complete the body dysmorphic disorder questionnaire 
(BDDQ) (figure 1) which is a validated screening questionnaire for identifying BDD. 
In order to screen positive on the BDDQ the person must answer yes to the first 2 
questions, which indicates that they are worried about how they look and wish they 
could think about their appearance less. Their main concern must not be that they 
are too fat. The person must then answer yes to at least 2 of the next 4 questions 
showing evidence of a significant impact on their daily life. In the final question, they 
must indicate that they think about their appearance either for 1-3 hours or greater 
than 3 hours per day. The BDDQ has been shown to have a sensitivity of 100% and 
specificity of 90% for detecting BDD10, although its use is as a screening tool and 
further assessment by an appropriate professional is required to diagnose BDD. 
 
Patients were also asked to complete the sino-nasal outcome test 23 (SNOT-23)13. 
We also performed nasal inspiratory peak flow (NIPF) measurements on all our 
patients as an objective measure of nasal patency14. 
 
Patients underwent consultation with the clinician and those with a high risk of 
having BDD were referred to the clinical psychologist, if they consented to this. 
Following this, the patient was then reviewed again in the rhinology clinic and a 
management plan was agreed based on the clinical findings and the 
recommendation of the clinical psychologist.  
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Controls 
We recruited 50 consecutive patients from an otology clinic in whom it was confirmed 
there was no rhinological history and performed the same screening assessment for 
BDD with the BDDQ. 
 
Statistical Methods: 
Data was collected using Microsoft Excel and statistical analysis was carried out 
using SPSS release 21.0 for Windows (SPSS Inc., Chicago, IL, USA). Statistical 
significance was attributed when p < 0.05. All results are described as means and 
standard deviations unless otherwise stated.  
 
Results: 
We recruited 84 patients consecutively into the study. A total of 34 were from the 
rhinology clinic and had been referred for consideration of septorhinoplasty surgery. 
Their mean age was 36.8 [±12.3] with 23 (67.6%) males and 11 (32.3%) females. 
The mean age of our control group was 51.8 [± 21.7] of whom 22 (44%) were males 
and 28 (56%) were females 
 
Of the rhinology patients, 11 (32%) were positive on the BDDQ score indicating a 
high risk for BDD. 6 of these were male (26% of the total number of males) and 5 
were female (45% of the total number of females).  
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They were all referred for psychological assessment following which 7 (63%) 
patients were felt to be unsuitable for surgery and were offered psychological 
treatment by the clinical psychology team. 
The mean age in the BDD positive group was 31.8 [±SD] compared to 39.2 [±SD] in 
the BDD negative group. The subjective patient outcome scores were significantly 
higher in the BDD positive group than the negative group indicating a greater 
negative impact on quality of life (SNOT 23: 83.8 ±14.3 v 39.4 ± 22.4; p< 0.01; 
r=0.521]. When we compared the nasal inspiratory peak flow measurements 
between the groups, there was no significant difference between the BDD positive 
group and the BDD negative group [NIPF 68.2 ± 25.6 v 82.2 ± 31.9; p < 0.2]. 
 
In the control group, 2 patients were identified as high risk for BDD, both of whom 
were female. They all screened negative for rhinological problems indicating no 
concern with their nose. The prevalence of BDD in the control group as a whole was 
4%, all of whom were females. 
  
Many of the patients in this study have not yet undergone their surgery or are only in 
the early post-operative phase. 
 
There is one patient who was negative on the BDDQ pre-operatively although he did 
admit to thinking about his nose for 1-3 hours per day. His motivation for surgery was 
to improve nasal function. This aim was achieved but there was an unintentional 
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change to his external appearance. His post-operative BDDQ was strongly positive, 
stating that he now thinks about his appearance more than 3 hours per day.  
 
Discussion 
Synopsis of key findings 
This prospective study has shown a prevalence of 32% of people at high risk of BDD 
according to the body dysmorphic disorder questionnaire (BDDQ). When gender is 
taken into account, the prevalence increases amongst females to 45% and 
decreases to 26% amongst males. The prevalence in our control group was 4% with 
a higher proportion once again in female patients.  
 
Our study revealed that 63% of those referred for psychological assessment were 
confirmed to have a presentation consistent with a BDD diagnosis and deemed not 
to be suitable for nasal surgery as it was felt they would have a poor outcome from a 
mental health perspective. The remaining patients in the surgery cohort (36%) did 
exhibit elements of BDD, though it was believed they had realistic functional, 
aesthetic and psychosocial expectations of what could be achieved through surgery, 
so that the risk of dissatisfaction was low post-operatively.   
 
We also showed that a high index of clinical suspicion should always remain in spite 
of a low risk on the BDDQ. In our cohort, we had one patient who developed BDD 
post-operatively in spite of having a good functional and aesthetic outcome. In 
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hindsight, he did show a tendency to this condition pre-operatively as although he 
claimed to have no cosmetic concerns, he admitted to thinking about his appearance 
for 1-3 hours per day. Attention to any ruminative component is therefore vital as it is 
one of the essential criteria for a BDD diagnosis. The nature of the BDDQ is such 
that we expect a number of false positives, however this finding will ensure that we 
maintain a high index of suspicion for BDD and refer patients on for psychological 
assessment in spite of a normal BDDQ in the future.  
 
Poirrier et al validated the SNOT 22 questionnaire in the septorhinoplasty population 
and demonstrated that the emotional questions (frustration and embarrassment) 
were highly relevant and equally improved following septorhinoplasty surgery15. This 
led to the validation of the SNOT 23 questionnaire. In this study, we utilised the 
SNOT-23 questionnaire as this has been validated for assessing quality of life in 
patients undergoing septorhinoplasty surgery13. The additional question in this latest 
version of the questionnaire asks whether the patient is concerned about the 
appearance of their nose. The SNOT-23 scores were significantly higher in the BDD 
positive group indicating that they felt that their quality of life was much poorer due to 
the nasal problem. It is the nature of subjective questionnaires that they are 
dependent on the individual patient’s perception of the problem. Therefore in a 
patient suffering body dysmorphic disorder related to the nose it would be expected 
that subjective impairment scores would be higher. It also highlights the difficulty in 
producing an objective measure of nasal blockage that correlates with subjective 
evaluation.  
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Interestingly, the bilateral NIPFs in the BDD group were lower than the non BDD 
group which, although non-significant, imply increased nasal blockage. However, this 
does highlight the difficulty in producing an objective measure of nasal blockage that 
equally correlates with the subjective evaluation of nasal blockage but also 
measures nasal airflow without patient effort16. 
 
While all the patients with BDD answered ‘yes’ to the question about concerns with 
appearance of the nose, many of those without BDD gave the same answer. 
Therefore this question alone could not be used to screen for this condition. 
 
Strengths of the study 
We know from the literature that patients undergoing septorhinoplasty surgery have 
a high prevalence of BDD9. We perform a large number of septorhinoplasty 
procedures (> 450/year) in our tertiary referral unit and therefore have a large cohort 
of patients to recruit from. Although the study was carried out over a 6 month period, 
we only recruited new patients for the first 2 months. The remaining time was used to 
follow up the participants. Along with the fact that the pressures of a busy clinic make 
it difficult to capture all potential participants, this is why the numbers of patients in 
the study are relatively small.  
 
We are fortunate to work collaboratively with the clinical psychology team of the 
Plastic & Reconstructive Surgery department which is able to support our practice. In 
future studies we aim to show that our treatment pathway ensures patients with BDD 
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are identified and offered appropriate treatment before surgery is considered. This 
will be achieved with the use of a scale that can show a change in score between the 
pre and post treatment such as the Cosmetic Procedure Screening Questionnaire17. 
We have a robust system in our unit ensuring that all patients who scored positive on 
the BDDQ are referred for an assessment by a clinical psychologist. The findings of 
this study confirm that this process is working effectively. We have also shown that 
patients with BDD have a poorer quality of life as highlighted by the higher SNOT-23 
scores. 
 
Comparison with other studies 
The finding that 32% of patients referred for consideration of septorhinoplasty 
surgery to our clinic are at high risk of BDD is higher than expected compared to 
other studies. However, if we exclude those patients who were assessed as 
appropriate for surgery, with only borderline BDD, the prevalence is reduced to 
20.6%.  
Seven previous studies12,18,19,20,21,22,23 (n = 1,001) have examined the prevalence of 
BDD in rhinoplasty surgery candidates. It ranges from 1.8%19 to 31.5%20 which 
represents a high degree of uncertainty. Veale et al (in submission)24  calculated a 
weighted prevalence of 20.1% in these studies with a wide confidence interval (9.9 - 
36.7). There was a slightly higher prevalence among males (18.4%) than females 
(16.7%), with the ratio being 0.91.  
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A number of factors may have led to there being such a broad range in prevalence of 
BDD; there was no consistency in the methods of assessment to screen for BDD or 
in its diagnostic criteria. There could be problems of inter-rater agreement in defining 
a ‘defect’ that is not significantly noticeable due to differences in defect evaluation. 
Also, none of the studies showed prospective evaluation of post-treatment 
satisfaction or persistence of BDD.  
These problems could be mitigated by the use of a standardised assessment for 
rhinoplasty25. This could involve an evaluation of the degree of discrepancy between 
the patient’s assessment of their appearance compared to the clinical rating of the 
perceived defect26 or compared to ideal ratings27 would potentially be of use. Along 
with similar assessments for post-operative outcome this could help determine if 
these measures can be used in the diagnosis of BDD or are better predictors of 
dissatisfaction.    
We found a prevalence of BDD in the control group of 4%. A study in Germany of 
over 2500 participants found a prevalence of 1.8%4. A North American study found a 
prevalence of BDD of 2.4% which, as we also found, showed higher rates among 
women (2.5%) compared to men (2.2%)28.The finding of an increased prevalence in 
this study could be because the BDDQ picks up mild cases of BDD. This is indicated 
in the treatment group by the fact that a number of patients who were positive were, 
following evaluation by a clinical psychologist, deemed suitable for surgery. A study 
proposing a framework for psychological assessment of patients requesting cosmetic 
surgery found that appearance related distress is more prevalent in London than 
other parts of the country29. This may also have had an impact on prevalence of 
BDD in this study. 
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Clinical applicability of the study 
Through this study we have shown that the BDDQ is a valid tool for identifying 
patients at risk of BDD. An experienced rhinologist may be able to make a 
judgement as to the suitability of a patient for surgery based on an assessment in the 
clinic. However this questionnaire is of particular use to the less experienced 
rhinologist and also in those cases where it is more difficult to identify if there is a 
problem.  
 
We have also shown the great advantage of having a close working relationship with 
a clinical psychologist. In our study the clinical psychologists confirmed that 63% of 
those patients referred with a positive score on the BDDQ were probably not suitable 
for surgery. However they felt that the remaining 36% were suitable. In certain cases 
the suitability was initially withheld until after a number of sessions with the 
psychologist. Issues that could be addressed during these sessions included helping 
those with a compulsive element to their condition where they frequently touch the 
nose. It was also possible to discuss in detail with the patient the realistic aims of the 
surgery, both functionally and cosmetically. The psychologist could then confidently 
confirm that the risk of post-operative dissatisfaction was low. The psychologist also 
helped the patient to consider how to manage in the event that there is a 
complication so that at least some of their expectations of surgery would be unmet. 
Within the National Health Service it is usually only reasonable to be offering 
functional septorhinoplasty to patients. However, inevitably there is often a cosmetic 
component to the procedure as a change to the external appearance is sometimes 
essential to improve function.  
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Conclusion 
Body dysmorphic disorder is a diagnosis that needs to be identified to ensure 
patients undergo appropriate treatment in the form of cognitive behaviour therapy 
and SSRI medication where required. Patients that are not identified and undergo 
cosmetic procedures have been shown to be more dissatisfied and it can worsen 
their BDD presentation. We have shown that the prevalence of undiagnosed BDD is 
high in patients undergoing septorhinoplasty surgery as identified by the body 
dysmorphic disorder questionnaire and feel that clinicians undertaking these types of 
procedures should consider utilising the BDDQ in routine practice as well as 
maintaining a high index of suspicion. 
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Figure 1: Body Dysmorphic Disorder Questionnaire 
 
 
 
 
